Shareholding disclosure

IGEA Pharma N.V.

Collectively declared rate

53.32%

Threshold

Crossed upwards

Timeline

Published

29.11.2019

Transaction

20.11.2019

Transfer date

20.03.2020

Voting rights breakdown

Voting rights acquired53.32%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 4

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBJBS00020

Beneficial owner

Giovanni Mazzaro

Declared address

Giovanni Mazzaro, Milano

Acquisition of shares as consideration in connection with IGEA's contemplated acquisition of a stake in the spin-off of the med-tech activities of Meditalia S.r.l. Closing of the transaction is currently expected to occur not later than 20 March 2020. The shares to be acquired will be subject to lock-up for the duration of one year.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open